World's first surgical repair of bilateral common iliac artery agenesis.

Ann R Coll Surg EnglJan 12, 2026 (epub)

T Ali, O Woolf, B Farquharson

✦ AI-curated · Sources linked

Case in brief

A 23-year-old woman was found incidentally on abdominal CT to have congenitally absent bilateral common iliac arteries and aortic occlusion below the renal arteries. Hypertrophied collateral vessels supplied blood flow to her lower limbs. After claudication and functional limitations worsened despite conservative management, she underwent surgical revascularisation with an aorto-bifemoral bypass using an axillary-bifemoral graft. Recovery was successful, and she was symptom-free two years after surgery.

What made this case unusual

The report describes surgical repair of bilateral common iliac artery agenesis, an anatomical abnormality the authors identify as rare, and a novel use of a Gore heparin-bonded graft.

Diagnostic / clinical pearl

In this case, hypertrophied collaterals maintained lower-limb flow despite congenital absence of both common iliac arteries and infrarenal aortic occlusion; CT identified the anatomy incidentally.

Source

Published in Ann R Coll Surg Engl. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Vascular Surgery

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.